Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX
Lineage Therap (LCTX) Ownership - Who Owns Lineage Therap?
1,794 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 08, 2024 | Don Bailey Director | Bought | $100001 |
| Feb 08, 2024 | Broadwood Partners Lp Director, >10% Owner | Bought | $7000001 |
| Jan 02, 2024 | Anula Jayasuriya Director | Bought | $10900 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $10900 | |
| Dec 31, 2023 | Bought | $2323466 | |
| Dec 31, 2023 | Sold | $5416945 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 83,420,138 | Insider | 44.18% | 86,756,944 | |
| 34,093,007 | Insider | 18.06% | 35,456,727 | |
| 7,854,626 | Institution | 4.16% | 8,168,811 | |
| 7,338,576 | Institution | 3.89% | 7,632,119 | |
| 6,888,942 | Insider | 3.65% | 7,164,500 | |
| 4,969,675 | Institution | 2.63% | 5,168,462 | |
| 4,369,028 | Institution | 2.31% | 4,543,789 | |
| 2,131,621 | Institution | 1.13% | 2,216,886 | |
| 1,581,471 | Institution | 0.84% | 1,644,730 | |
| 1,410,750 | Institution | 0.75% | 1,467,180 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,338,576 | Institution | 3.89% | 7,632,119 | |
| 1,581,471 | Institution | 0.84% | 1,644,730 | |
| 1,410,750 | Institution | 0.75% | 1,467,180 | |
| 767,100 | Institution | 0.41% | 797,784 | |
| 611,923 | Institution | 0.32% | 636,400 | |
| 447,020 | Institution | 0.24% | 464,901 | |
| 363,215 | Institution | 0.19% | 377,744 | |
| 128,266 | Institution | 0.07% | 133,397 | |
| 99,941 | Institution | 0.05% | 103,939 | |
| 67,474 | Institution | 0.04% | 70,173 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,416,552 | Institution | 2.34% | 6,536,497 | |
| 2,814,846 | Institution | 1.49% | 4,165,972 | |
| 2,964,018 | Institution | 1.57% | 3,082,579 | |
| 1,124,024 | Institution | 0.60% | 1,168,985 | |
| 499,580 | Institution | 0.26% | 739,378 | |
| 280,986 | Institution | 0.15% | 292,225 | |
| 115,770 | Institution | 0.06% | 171,340 | |
| 7,878 | Institution | <0.01% | 11,659 | |
| 3,702 | Institution | <0.01% | 4,035 | |
| 255 | Institution | <0.01% | 265 |
FAQ
Who Owns Lineage Cell Therapeutics, Inc. (LCTX)?
Currently, no data Available
What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors?
Currently, no data Available
What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX)?
Broadwood Partners Lp owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.